Project description
Transforming medicine with onsite 3D printing
In the realm of medicine, one size does not fit all. The challenges of uniform drug treatments, especially for diverse patient groups like children and the elderly, have long been apparent. Enter the PMed project, funded by the European Innovation Council and led by CurifyLabs. Addressing the gap between personalised medicine knowledge and practical application, CurifyLabs is introducing the Pharma Kit. This is a groundbreaking technology enabling onsite 3D printing of tailored medicines in pharmacies. The innovation promises to consider patients’ age, metabolic variations, and genetic differences, paving the way for industry-level standards in mass customisation. With a focus on developing scalable 3D printing formulations and quality control methods, PMed signals a transformative leap towards personalised healthcare.
Objective
Uniform drug treatments are not always the best option for treating some patient populations – including children and the elderly. The industry now has extensive knowledge on the benefits of personalized medicines that take the age, metabolic and genetic differences of patients into account. However, until now there has not been a practical manufacturing solution to put this knowledge into wide-scale use.
CurifyLabs has created a technology called MiniLab to make high-quality 3D printing of personalized medicines available on site in the pharmacies and bring industry level standards to mass customisation of medicines. In this project we will finalize a standard process for developing 3D printing compatible formulations and quality control solutions. This will make MiniLab highly scalable across different therapeutic areas.
Fields of science
Keywords
Programme(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Funding Scheme
HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended FinanceCoordinator
00180 Helsinski
Finland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.